PMID: 9438909Jan 24, 1998Paper

Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1

Journal of Dermatological Science
A HasanV Falanga

Abstract

Failure to reepithelialize is the major clinical problem in venous ulcers. It is not clear whether the problem resides with keratinocytes or with inadequate and improper formation of extracellular matrix. In this study, we characterized the biosynthetic activity and response to transforming growth factor-beta 1 (TGF-beta) of dermal fibroblast cultures isolated from biopsies of venous ulcers and from normal thigh skin (controls) of seven patients. We found that baseline 3H-proline incorporation was similar in fibroblasts from venous ulcers and control skin (p= 0.1716). No difference was detected by ELISA between ulcer and control fibroblasts in the synthesis of total TGF-beta (p = 0.2309), and the mRNA levels for alpha 1(I) procollagen and TGF-beta were comparable in both groups. However, TGF-beta (0.1-5 ng/ml) enhanced collagen protein synthesis by more than 60% and in a dose-dependent manner (r = 0.997) in control fibroblast cultures, while failing to stimulate collagen production by venous ulcer fibroblasts (p = 0.0001). This unresponsiveness to TGF-beta was associated with up to a fourfold decrease in TGF-beta Type II receptors. We conclude that fibroblasts from the edge of non-healing venous ulcers are unresponsive to the a...Continue Reading

References

Jul 1, 1979·Analytical Biochemistry·D F Webster, W Harvey
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A B RobertsJ H Kehrl
Jun 18, 1988·British Medical Journal·P D Coleridge SmithJ A Dormandy
Jul 31, 1982·Lancet·N L Browse, K G Burnand
Apr 17, 1993·Lancet·V Falanga, W H Eaglstein
Aug 1, 1996·Burns : Journal of the International Society for Burn Injuries·V MoulinL Germain
Oct 1, 1995·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·A B Roberts
Apr 1, 1995·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·V FalangaA Moshell
Apr 1, 1995·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·M C RobsonG A Ksander

❮ Previous
Next ❯

Citations

Feb 6, 2004·Blood Cells, Molecules & Diseases·Evangelos V Badiavas
Feb 6, 2004·Blood Cells, Molecules & Diseases·Vincent Falanga
Mar 27, 2002·Clinics in Geriatric Medicine·Dana Paquette, Vincent Falanga
Jul 19, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A Pérez-AisaA Lanas
Apr 26, 2000·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·V Falanga, M Sabolinski
Feb 21, 2004·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Martin C RobsonMichael G Franz
Feb 14, 2009·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Silvestro CanonicoAndrea Fattopace
Jan 19, 2002·BMJ : British Medical Journal·K G HardingG K Patel
Jan 14, 2010·Molecular Medicine·Irena PastarMarjana Tomic-Canic
Dec 14, 2005·American Journal of Clinical Dermatology·Richard D PriceHarshad A Navsaria
Nov 20, 2012·Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India·A S HalimA Z Mat Saad
Dec 1, 2012·Stem Cells Translational Medicine·Luis Rodriguez-MenocalEvangelos Van Badiavas
Sep 10, 2014·Life Sciences·Dania AkbikRamin Rohanizadeh
Apr 20, 2011·Journal of Cell Communication and Signaling·Christopher G Elliott, Douglas W Hamilton
Jun 12, 2014·Expert Review of Molecular Diagnostics·Ferdinando MannelloJoseph D Raffetto
Sep 6, 2013·Expert Opinion on Emerging Drugs·Ganary DabiriVincent Falanga
Jul 13, 2005·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Gregory SchultzKarl Claxton
Mar 26, 2003·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Gregory S SchultzWolfgang Vanscheidt
May 26, 2006·International Wound Journal·Gregory S SchultzUNKNOWN Wound Bed Advisory Board Members
Mar 6, 2008·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·J Michael SorrellArnold I Caplan
Jul 26, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Thomas A DavisDouglas Tadaki
Jan 20, 2010·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Jaymie PanuncialmanVincent Falanga
Jun 12, 2004·The Journal of Investigative Dermatology·Koji SumiyoshiHideoki Ogawa
Jul 15, 2015·Advances in Wound Care·Eleri M JonesSteven L Percival
Jul 9, 2009·International Review of Cell and Molecular Biology·J Michael Sorrell, Arnold I Caplan
Jul 14, 2016·Tissue Engineering. Part B, Reviews·Yun XiaoMilica Radisic
Dec 3, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Bin SunBertha Chen
Jan 14, 2017·The Journal of Investigative Dermatology·Wei LiuGeoffrey C Gurtner
Nov 18, 2005·Lancet·Vincent Falanga
Aug 13, 2004·Vascular and Endovascular Surgery·Ricardo VasquezJoseph D Raffetto
May 6, 2005·The International Journal of Lower Extremity Wounds·Stefan BeckertHorst-Dieter Becker
Nov 26, 2010·Journal of Dental Research·S EnochP Stephens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.